Literature DB >> 27861762

Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.

A Aggarwal1, A N Sarangi2, P Gaur1, A Shukla1, R Aggarwal3.   

Abstract

In Asia, enthesitis-related arthritis (ERA) is the most frequent category of juvenile idiopathic arthritis. ERA has a strong association with human leucocyte antigen (HLA)-B27 and subclinical gut inflammation. In an HLA-B27 transgenic rat model, the presence of Bacteroides bacteria in the gut appears to cause spondyloarthropathy (SpA). Thus, we studied gut microbiota in children with ERA. Stool specimens from 33 patients with ERA and 14 age-matched healthy controls were studied; none had any gastrointestinal symptom, or had received a drug known to affect gut motility or microbiota in the preceding 6 weeks. From each specimen, a cDNA library for the V3 region of bacterial 16S rRNA was subjected to high-throughput, massively parallel sequencing. Relationship of the specimens was studied using principal co-ordinate analysis (PCoA), and abundances of various bacterial taxa and alpha diversity were compared between groups. In eight patients, a repeat faecal specimen was studied after 12 weeks of probiotic therapy. The 55 specimens yielded a median (range) of 397 315 (102 093-1 502 380) high-quality reads each. In PCoA, gut microbiota from ERA showed a wider dispersion than those from controls. In patients, families Bacteroidaceae and Enterobacteriaceae were more abundant and Prevotellaceae were less abundant than in controls. Also, genera Bacteroides, Entercoccus and Klebsiella were over-represented and genus Prevotella was under-represented in ERA patients. Probiotic therapy led to a non-significant increase in Prevotellaceae. Patients with ERA have a dysbiosis in the gut, with increased abundance of Bacteroides and reduction of Prevotella. Probiotic supplementation in a subset of patients did not reverse these changes significantly.
© 2016 British Society for Immunology.

Entities:  

Keywords:  gut; juvenile arthritis; microbiome

Mesh:

Substances:

Year:  2016        PMID: 27861762      PMCID: PMC5290238          DOI: 10.1111/cei.12900

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria.

Authors:  T Ayabe; D P Satchell; C L Wilson; W C Parks; M E Selsted; A J Ouellette
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

Review 2.  The intestinal microbiome in spondyloarthritis.

Authors:  Tejpal Gill; Mark Asquith; James T Rosenbaum; Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

3.  Faecal microbiome in new-onset juvenile idiopathic arthritis.

Authors:  M V Tejesvi; M Arvonen; S M Kangas; P L Keskitalo; A M Pirttilä; T J Karttunen; P Vähäsalo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

4.  Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.

Authors:  Vinaya Kunjir; Anuradha Venugopalan; Arvind Chopra
Journal:  J Rheumatol       Date:  2010-06-01       Impact factor: 4.666

Review 5.  The Link Between Klebsiella and Ankylosing Spondylitis in Worldwide Geographical Locations.

Authors:  Taha Rashid; Alan Ebringer; Clyde Wilson
Journal:  Curr Rheumatol Rev       Date:  2016

6.  Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis?

Authors:  N Saxena; R Misra; A Aggarwal
Journal:  Rheumatology (Oxford)       Date:  2006-03-07       Impact factor: 7.580

7.  A sequential study of the relationship between faecal Klebsiella aerogenes and the common clinical manifestations of ankylosing spondylitis.

Authors:  C J Eastmond; M Calguner; R Shinebaum; E M Cooke; V Wright
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

Review 8.  Gastrointestinal lesions associated with spondyloarthropathies.

Authors:  Ambrogio Orlando; Sara Renna; Giovanni Perricone; Mario Cottone
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 9.  Ankylosing spondylitis is linked to Klebsiella--the evidence.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 3.650

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  16 in total

1.  Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Authors:  Lampros Fotis; Nurmohammad Shaikh; Kevin W Baszis; Charles M Samson; Raffi Lev-Tzion; Anthony R French; Phillip I Tarr
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

2.  Identification of Prevotella Oralis as a possible target antigen in children with Enthesitis related arthritis.

Authors:  Matthew L Stoll; L Wayne Duck; Margaret H Chang; Robert A Colbert; Peter A Nigrovic; Susan D Thompson; Charles O Elson
Journal:  Clin Immunol       Date:  2020-05-11       Impact factor: 3.969

3.  Juvenile Idiopathic Arthritis and the Gut Microbiome: More Clues, More Questions.

Authors:  Daniel B Horton
Journal:  Arthritis Rheumatol       Date:  2019-05-06       Impact factor: 10.995

Review 4.  The microbiome and HLA-B27-associated acute anterior uveitis.

Authors:  James T Rosenbaum; Mark Asquith
Journal:  Nat Rev Rheumatol       Date:  2018-12       Impact factor: 20.543

Review 5.  The role of gut microbiota in the effects of maternal obesity during pregnancy on offspring metabolism.

Authors:  Liyuan Zhou; Xinhua Xiao
Journal:  Biosci Rep       Date:  2018-04-13       Impact factor: 3.840

6.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

Review 7.  Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Authors:  Silvia Menegatti; Elisabetta Bianchi; Lars Rogge
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

8.  Characterization of microbiota in systemic-onset juvenile idiopathic arthritis with different disease severities.

Authors:  Yan-Qing Dong; Wei Wang; Ji Li; Ming-Sheng Ma; Lin-Qing Zhong; Qi-Jiao Wei; Hong-Mei Song
Journal:  World J Clin Cases       Date:  2019-09-26       Impact factor: 1.337

9.  Age and fecal microbial strain-specific differences in patients with spondyloarthritis.

Authors:  Matthew L Stoll; Pamela F Weiss; Jennifer E Weiss; Peter A Nigrovic; Barbara S Edelheit; S Lou Bridges; Maria I Danila; Charles H Spencer; Marilynn G Punaro; Kenneth Schikler; Andreas Reiff; Ranjit Kumar; Randy Q Cron; Casey D Morrow; Elliot J Lefkowitz
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

10.  Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study.

Authors:  Ankita Singh; Aditya N Sarangi; Amit Goel; Rajni Srivastava; Rajat Bhargava; Priyanka Gaur; Amita Aggarwal; Rakesh Aggarwal
Journal:  BMC Gastroenterol       Date:  2018-06-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.